M. Badminton

M. Badminton, D. Mirza, E. Elias, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Heparin Selectively Affects the Quantification of MicroRNAs in Human Blood Samples

M. F. Stewart, M. Badminton, J. Rhodes, 2013 .

Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria.

M. Worwood, M. Badminton, G. Elder, 2007, Blood.

Serum 25‐hydroxyvitamin D in erythropoietic protoporphyria

M. Badminton, G. Elder, A. Anstey, 2008, The British journal of dermatology.

The cutaneous porphyrias.

M. Badminton, A. Anstey, R. Katugampola, 2014, Dermatologic clinics.

Role of genetic testing in the management of patients with inherited porphyria and their families

M. Badminton, S. Whatley, 2013, Annals of clinical biochemistry.

protoporphyria Erythropoiesis and iron metabolism in dominant erythropoietic

M. Worwood, M. Badminton, G. Elder, 2013 .

Liver transplantation from donors with acute intermittent porphyria.

M. Badminton, B. Gunson, P. Newsome, 2011, Annals of internal medicine.

ferrochelatase gene in hematopoietic cells secondary to late-onset protoporphyria caused by deletion of a Photosensitivity and acute liver injury in myeloproliferative disorder

Geraint T. Williams, M. Badminton, G. Elder, 2013 .

Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells.

Geraint T. Williams, M. Badminton, G. Elder, 2006, Blood.

Update review of the acute porphyrias

P. Stein, M. Badminton, D. Rees, 2017, British journal of haematology.

Treatment of an acute attack of porphyria during pregnancy

J. Deybach, M. Badminton, 2006, European journal of neurology.

The Porphyrias and Other Disorders of Porphyrin Metabolism

M. Badminton, G. Elder, A. Deacon, 2012 .

Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria.

G. Mufti, S. Ibbotson, G. Murphy, 2011, The Journal of investigative dermatology.

Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life

A. Finlay, M. Badminton, G. Elder, 2006, The British journal of dermatology.

Late‐onset erythropoietic protoporphyria in association with haematological malignancy

M. Badminton, S. Whatley, H. K. Bell, 2006, Clinical and experimental dermatology.

Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease

M. Badminton, G. Elder, H. Dailey, 2004, Journal of Medical Genetics.

Changes in free calcium in the endoplasmic reticulum of living cells detected using targeted aequorin.

A. Campbell, J. Kendall, M. Badminton, 1994, Analytical biochemistry.

Recombinant apoaequorin acting as a pseudo-luciferase reports micromolar changes in the endoplasmic reticulum free Ca2+ of intact cells.

A. Campbell, J. Kendall, M. Badminton, 1996, The Biochemical journal.

EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks

H. Bonkovsky, P. Stein, S. Sandberg, 2016 .

Audit of the Use of Regular Haem Arginate Infusions in Patients with Acute Porphyria to Prevent Recurrent Symptoms.

M. F. Stewart, P. Stein, J. Marsden, 2015, JIMD reports.

Best practice guidelines on clinical management of acute attacks of porphyria and their complications

M. F. Stewart, P. Stein, M. Badminton, 2013, Annals of clinical biochemistry.

Congenital erythropoietic porphyria: a single‐observer clinical study of 29 cases

A. Finlay, C. Ged, X. Schneider-Yin, 2012, The British journal of dermatology.

Fundamental Ca2+ Signaling Mechanisms in Mouse Dendritic Cells: CRAC Is the Major Ca2+ Entry Pathway

D. Clapham, M. Jackson, V. Klyachko, 2001, The Journal of Immunology.

Fundamental Ca Signaling Mechanisms in Mouse Dendritic Cells: CRAC Is the Major Ca Entry Pathway

D. Clapham, V. Klyachko, A. Thomson, 2001 .

Fundamental Ca 2 1 Signaling Mechanisms in Mouse Dendritic Cells : CRAC Is the Major Ca 2 1 Entry Pathway

D. Clapham, M. Jackson, V. Klyachko, 2001 .

Entry Pathway 2+ CaMouse Dendritic Cells: CRAC Is the Major Signaling Mechanisms in 2+ Fundamental Ca

D. Clapham, M. Jackson, V. Klyachko, 2001 .

Best practice guidelines on first-line laboratory testing for porphyria

M. F. Stewart, J. Marsden, M. Badminton, 2017, Annals of clinical biochemistry.

Abstracts presented at the 24th Annual Congress of the Belgian Society of Internal Medicine, 13–14 December 2019, Dolce La Hulpe, La Hulpe, Belgium

H. Bonkovsky, S. Goldman, P. Stein, 2019 .

Bovine congenital erythropoietic protoporphyria in a crossbred limousin heifer in Ireland

M. Badminton, M. Doherty, C. McAloon, 2015, Irish Veterinary Journal.

Differences in stability of recombinant apoaequorin within subcellular compartments.

J. Kendall, M. Badminton, G. Sala-Newby, 1995, Biochemical and biophysical research communications.

Update on the diagnosis and management of the autosomal dominant acute hepatic porphyrias

M. Badminton, D. Schulenburg-Brand, D. Rees, 2022, Journal of Clinical Pathology.

A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases

A. Finlay, C. Ged, X. Schneider-Yin, 2012, The British journal of dermatology.

Allogeneic bone marrow transplantation in a 7‐year‐old girl with congenital erythropoietic porphyria: a treatment dilemma

M. Badminton, C. Y. Tan, C. Moss, 2007, The British journal of dermatology.

European porphyria initiative (EPI): a platform to develop a common approach to the management of porphyrias and to promote research in the field.

S. Sandberg, S. Parker, E. Minder, 2006, Physiological research.

International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias

H. Bonkovsky, S. Sandberg, R. Desnick, 2019, Genetics in Medicine.

Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene.

R. Newcombe, M. Badminton, G. Elder, 2009, Clinical chemistry.

MANAGEMENT OF ACUTE AND CUTANEOUS PORPHYRIAS

M. Badminton, G. Elder, G. Elder, 2002, International journal of clinical practice.

Liver Transplantation for Acute Intermittent Porphyria is Complicated by a High Rate of Hepatic Artery Thrombosis

M. Badminton, B. Gunson, D. Mirza, 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Semaphorin 3A growth cone collapse requires a sequence homologous to tarantula hanatoxin.

C. Woolf, M. Badminton, K. Mizuno, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Comparative structure-activity studies on mammalian [Arg8] LH-RH and chicken [Gln8] LH-RH by fluorimetric titration.

M. Badminton, R. Millar, M. Fridkin, 1983, Biochemical and Biophysical Research Communications - BBRC.

C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload.

Joanne, J. Marsden, G. Mieli-Vergani, 2008, American journal of human genetics.

UK experience of liver transplantation for erythropoietic protoporphyria

M. Badminton, D. Mirza, P. Newsome, 2011, Journal of Inherited Metabolic Disease.

Pregnancy in a patient with congenital erythropoietic porphyria.

M. Badminton, A. Anstey, John Williams, 2007, The New England journal of medicine.

Liver transplantation as a cure for acute intermittent porphyria

M. Badminton, G. Elder, J. Rhodes, 2004, The Lancet.

Erythropoietic protoporphyria: a functional analysis of the leader sequence of human ferrochelatase.

M. Badminton, C. Cobbold, Andrew Roberts, 2006, Molecular genetics and metabolism.

Molecular mechanisms of dominant expression in porphyria

M. Badminton, G. Elder, 2005, Journal of Inherited Metabolic Disease.

An Audit of the Use of Gonadorelin Analogues to Prevent Recurrent Acute Symptoms in Patients with Acute Porphyria in the United Kingdom.

P. Stein, M. Badminton, D. Rees, 2017, JIMD reports.

Inherited Disorders of Haem Synthesis

M. Badminton, G. Elder, 2009 .

Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance.

M. F. Stewart, M. Badminton, G. Elder, 2009, The Journal of investigative dermatology.

Symptomatic response of erythropoietic protoporphyria to iron supplementation.

D. P. Bentley, M. Badminton, A. Anstey, 2007, Journal of the American Academy of Dermatology.

Molecular epidemiology of erythropoietic protoporphyria in the U.K.

M. Badminton, G. Elder, A. Anstey, 2010, The British journal of dermatology.

Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria.

M. Badminton, G. Elder, A. Anstey, 2007, The Journal of investigative dermatology.

European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program.

S. Sandberg, J. Marsden, J. Deybach, 2011, Clinical chemistry.

Exonic deletions as a cause of erythropoietic protoporphyria

M. Badminton, Lisa Wood, K. McKenna, 2006, Annals of clinical biochemistry.

Shedding light on recent advances in our understanding of cutaneous porphyrias

M. Badminton, J. Powell, 2018, The British journal of dermatology.

Mefenamic acid prevents assessment of drug abuse with EMIT assays.

M. Badminton, S. Rainbow, C. M. Dawson, 1993, Clinical chemistry.

Bristol Cup Posters

A. Finlay, C. Ged, H. Puy, 2009 .

Nucleoplasmin-targeted aequorin provides evidence for a nuclear calcium barrier.

A. Campbell, J. Kendall, M. Badminton, 1995, Experimental cell research.

Targeted bioluminescent indicators in living cells.

A. Campbell, J. Kendall, M. Badminton, 2000, Methods in enzymology.

Bioluminescent and Chemiluminescent Indicators for Molecular Signalling and Function in Living Cells

A. Campbell, K. Taylor, J. Kendall, 1999 .

CHAPTER 28 – The porphyrias: inherited disorders of haem synthesis

M. Badminton, G. Elder, 2014 .

Urinary catecholamines and metabolites in the immediate postoperative period following major surgery

M. Badminton, I. McDowell, H. Wheatley, 2004, Journal of Clinical Pathology.

Acute intermittent porphyria: fatal complications of treatment.

M. F. Stewart, P. Stein, R. Sarkany, 2012, Clinical medicine.

Clinical experience of trainees in chemical pathology: a survey of junior medical staff in the United Kingdom.

M. Badminton, P. Galloway, G. Bayly, 1998, Journal of Clinical Pathology.

Sclerodermatous changes of face, neck and scalp associated with familial porphyria cutanea tarda

M. Badminton, A. Anstey, J. Rendall, 2008, Clinical and experimental dermatology.

The molecular genetics of erythropoietic protoporphyria.

L. Gouya, H. Puy, M. Badminton, 2009, Cellular and molecular biology.

Use of a Non-Extraction HPLC Technique for Measuring Angiotensin-Converting Enzyme under Optimum Conditions

M. Badminton, S. Rainbow, T. Tickner, 1991, Annals of clinical biochemistry.

Retracing an old journey in variegate porphyria

M. Badminton, 2012, The British journal of dermatology.

FRI-442-Acute hepatic porphyria disease manifestations and daily life impacts in EXPLORE international, prospective, natural history study

H. Bonkovsky, P. Stein, S. Sandberg, 2019, Journal of Hepatology.

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

H. Bonkovsky, P. Stein, S. Sandberg, 2018, Hepatology.

An Analysis of Healthcare Utilization and Costs Associated with Patients with Acute Hepatic Porphyrias (AHPS) with Recurrent Attacks in Explore: A Prospective, Multinational Natural History Study of Patients with AHP

H. Bonkovsky, P. Stein, S. Sandberg, 2018 .

Pseudoexon activation in the HMBS gene as a cause of the nonerythroid form of acute intermittent porphyria.

M. F. Stewart, M. Badminton, J. Rhodes, 2013, Clinical chemistry.

Evaluation of a New Rapid Immunometric Method for the Measurement of the MB Isoenzyme of Creatine Kinase in Serum

M. Badminton, S. Rainbow, T. Tickner, 1992, Annals of clinical biochemistry.

Pseudoexon activation in the HMBS gene as a cause of the nonerythroid form of acute intermittent porphyria.

M. Badminton, V. Crowley, P. Reed, 2013, Clinical chemistry.